Several other molecules, including CD44, CD133, CD24, and CD166 are potential cancer stem cell markers that may contribute to CRC progression and metastasis [20]; therefore, we assessed if their expression correlated with that of EPHB3 in the CSC samples and controls. The gene discussed is ALCAM; the disease is cancer.